|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Stock-based compensation attributable to equity awards | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Other assets | |||||
| Trade accounts payable and accrued liabilities | |||||
| Current income taxes receivable / payable | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds from sale of assets | |||||
| Net cash used in investing activities | |||||
| Financing Activities | |||||
| Deferred financing fees | |||||
| Purchase of treasury stock | |||||
| Proceeds from issuance of common stock, net | |||||
| Dividends paid | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...